Haihong Shi

1.0k citations
52 papers · 754 indexed · h-index 17
Topics
Diabetes Treatment and Management (12 papers)Metabolism, Diabetes, and Cancer (9 papers)SARS-CoV-2 and COVID-19 Research (6 papers)

In The Last Decade

Haihong Shi

49 papers receiving 726 citations

Peers

Haihong Shi
Comparison fields: 5 of 107
  • Molecular Biology 238
  • Endocrinology, Diabetes and Metabolism 149
  • Oncology 147
  • Infectious Diseases 136
  • Spectroscopy 76
Replace Dhruvanshu Parmar with:
Dhruvanshu Parmar India
Enaksha Wickremsinhe United States
Rao N. V. S. Mamidi United States
Katrijn Bogman Switzerland
Arian Emami Riedmaier United States
Ahmad Y. Abuhelwa Australia
Kelly Bleasby United States
Elena Guerini Switzerland
Rucha Sane United States
Takenori Niioka Japan
Haihong Shi relative to Dhruvanshu Parmar India Dhruvanshu Parmar's profile →
Citations per field
00.5×6.2×
Dhruvanshu Parmar · 1×
Citations per year

Countries citing papers authored by Haihong Shi

Since Specialization
Citations

This map shows the geographic impact of Haihong Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haihong Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haihong Shi more than expected).

Fields of papers citing papers by Haihong Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haihong Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haihong Shi. The network helps show where Haihong Shi may publish in the future.

Co-authorship network of co-authors of Haihong Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Haihong Shi. A scholar is included among the top collaborators of Haihong Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haihong Shi. Haihong Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 3
4 0
5 0
6 3
7 1
8 9
9 5
10 2
11 7
12 8
13 39
14 10
15 19
16 19
17 4
18 15
19 41
20 36

About Haihong Shi

Haihong Shi is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Physiology, having authored 52 papers that have together received 754 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (12 papers), Metabolism, Diabetes, and Cancer (9 papers) and SARS-CoV-2 and COVID-19 Research (6 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (149 citations), Infectious Diseases (136 citations) and Pharmacology (59 citations). Haihong Shi has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Vaishali Sahasrabudhe, Steven G. Terra, Anne Hickman, Naidong Weng, Ranran Yang, Ting Yue, Kyle Matschke, Ruyin Long, Yanke Yu and Susan Zhou. Their work appears in journals such as Cancer Research, The Lancet Oncology and Energy Policy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026